Recall Ledger

Papaverine HCl Injection recall (American Regent, Inc.)

DrugClass IOngoing

Summary: American Regent, Inc. is recalling Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.. Reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde.

What is being recalled

Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Why

Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

How serious is it

Class I is the most serious level: FDA considers there is a reasonable probability that using or being exposed to this product will cause serious health problems or death.

Where it was sold

Nationwide within the U.S

How to tell if yours is affected

Lot #: 25202, Exp. Date: 11/30/2026.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0800-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass I
StatusOngoing
Recall startedJuly 24, 2026
ReportedAugust 26, 2026
CompanyAmerican Regent, Inc.
Company locationShirley, NY, United States
Initiated byVoluntary: Firm initiated
Quantity86,100 vials

More recalls from American Regent, Inc. · all drug recalls · recalls from July 2026

Official FDA record